Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
Year: 1998
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Institutions: The University of Texas at San Antonio Health Science Center, Audie L. Murphy Memorial VA Hospital, Memorial Hermann, Maimonides Medical Center, Louisiana State University Health Sciences Center Shreveport, The University of Texas Southwestern Medical Center, Tufts University, University of Hawaiʻi at Mānoa, University of Hawaii System, Penn State Milton S. Hershey Medical Center, University of New Mexico, University of Cincinnati, University of South Florida, University of Manitoba, Bayer (United States)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2153961239